ALK-Abelló A/S (ALK-B.CO)

DKK 146.4

(1.04%)

Inventory Summary of ALK-Abelló A/S

  • ALK-Abelló A/S's latest annual inventory in 2023 was 1.42 Billion DKK , up 9.71% from previous year.
  • ALK-Abelló A/S's latest quarterly inventory in 2024 Q2 was 1.59 Billion DKK , up 6.7% from previous quarter.
  • ALK-Abelló A/S reported annual inventory of 1.29 Billion DKK in 2022, up 7.72% from previous year.
  • ALK-Abelló A/S reported annual inventory of 1.2 Billion DKK in 2021, up 10.16% from previous year.
  • ALK-Abelló A/S reported quarterly inventory of 1.49 Billion DKK for 2024 Q1, up 4.92% from previous quarter.
  • ALK-Abelló A/S reported quarterly inventory of 1.39 Billion DKK for 2023 Q2, up 5.38% from previous quarter.

Annual Inventory Chart of ALK-Abelló A/S (2023 - 2005)

Historical Annual Inventory of ALK-Abelló A/S (2023 - 2005)

Year Inventory Inventory Growth
2023 1.42 Billion DKK 9.71%
2022 1.29 Billion DKK 7.72%
2021 1.2 Billion DKK 10.16%
2020 1.09 Billion DKK 3.5%
2019 1.05 Billion DKK 6.34%
2018 993 Million DKK 13.49%
2017 875 Million DKK 29.44%
2016 676 Million DKK 30.0%
2015 520 Million DKK 27.45%
2014 408 Million DKK 21.43%
2013 336 Million DKK 13.9%
2012 295 Million DKK 1.37%
2011 291 Million DKK -6.13%
2010 310 Million DKK 3.33%
2009 300 Million DKK 2.74%
2008 292 Million DKK 3.55%
2007 282 Million DKK -1.74%
2006 287 Million DKK -3.69%
2005 298 Million DKK 0.0%

Peer Inventory Comparison of ALK-Abelló A/S

Name Inventory Inventory Difference
Bavarian Nordic A/S 1.64 Billion DKK 13.429%
Genmab A/S 57 Million DKK -2396.491%
Gubra A/S -403.98 Million DKK 452.237%
Novo Nordisk A/S 31.81 Billion DKK 95.527%
Orphazyme A/S -1099.00 DKK 129481446.679%
Pharma Equity Group A/S 1000.00 DKK -142299900.0%
Zealand Pharma A/S 7.93 Million DKK -17833.207%